Abstract
Testing of the susceptibility to 12 antimicrobial agents, including beta-lactams, aminoglycosides, ciprofloxacin, and erythromycin, was performed by broth microdilution on 78 consecutive clinical isolates of Nocardia asteroides. Surprisingly, a limited number of patterns of susceptibility were identified that included all drug classes, with 95% of isolates exhibiting one of five patterns. One group (17%) exhibited resistance to the broad-spectrum cephalosporins, one group (18%) was susceptible to both ampicillin and erythromycin, one group (17%) was susceptible to ampicillin and carbenicillin but intermediate in susceptibility to imipenem, and the most common group (35%) was resistant to ampicillin but susceptible to the broad-spectrum cephalosporins and imipenem. The most active parenteral agents were amikacin (95%), imipenem (88%), ceftriaxone (82%), and cefotaxime (82%), while the most active oral agents were the sulfonamides (100%), minocycline (100%), and ampicillin (40%). Additional studies are needed to determine whether differences in beta-lactamases relate to varying beta-lactam resistance and whether taxonomic differences that correlate with the different susceptibility groups can be identified.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BAUER A. W., SHERRIS J. C. THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA. Chemotherapy. 1964;9(1):1–19. doi: 10.1159/000220337. [DOI] [PubMed] [Google Scholar]
- Bach M. C., Sabath L. D., Finland M. Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother. 1973 Jan;3(1):1–8. doi: 10.1128/aac.3.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cynamon M. H., Palmer G. S. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins. Antimicrob Agents Chemother. 1981 Dec;20(6):841–842. doi: 10.1128/aac.20.6.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dalovisio J. R., Pankey G. A. In vitro susceptibility of Nocardia asteroides to amikacin. Antimicrob Agents Chemother. 1978 Jan;13(1):128–129. doi: 10.1128/aac.13.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dewsnup D. H., Wright D. N. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents. Antimicrob Agents Chemother. 1984 Feb;25(2):165–167. doi: 10.1128/aac.25.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gombert M. E., Aulicino T. M., duBouchet L., Berkowitz L. R. Susceptibility of Nocardia asteroides to new quinolones and beta-lactams. Antimicrob Agents Chemother. 1987 Dec;31(12):2013–2014. doi: 10.1128/aac.31.12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gombert M. E., Aulicino T. M., duBouchet L., Silverman G. E., Sheinbaum W. M. Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrob Agents Chemother. 1986 Aug;30(2):270–273. doi: 10.1128/aac.30.2.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gombert M. E. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982 Jun;21(6):1011–1012. doi: 10.1128/aac.21.6.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goodfellow M., Orchard V. A. Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J Gen Microbiol. 1974 Aug;83(2):375–387. doi: 10.1099/00221287-83-2-375. [DOI] [PubMed] [Google Scholar]
- Gutmann L., Goldstein F. W., Kitzis M. D., Hautefort B., Darmon C., Acar J. F. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams. Antimicrob Agents Chemother. 1983 Feb;23(2):248–251. doi: 10.1128/aac.23.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kitzis M. D., Gutmann L., Acar J. F. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. J Antimicrob Chemother. 1985 Jan;15(1):23–30. doi: 10.1093/jac/15.1.23. [DOI] [PubMed] [Google Scholar]
- Swenson J. M., Wallace R. J., Jr, Silcox V. A., Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985 Dec;28(6):807–811. doi: 10.1128/aac.28.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsukamura M. Numerical analysis of the taxonomy of Nocardiae and Rhodococci. Microbiol Immunol. 1982;26(12):1101–1119. doi: 10.1111/j.1348-0421.1982.tb00260.x. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Nash D. R., Johnson W. K., Steele L. C., Steingrube V. A. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid. J Infect Dis. 1987 Dec;156(6):959–966. doi: 10.1093/infdis/156.6.959. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Septimus E. J., Musher D. M., Martin R. R. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977 Apr;135(4):568–576. doi: 10.1093/infdis/135.4.568. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Steele L. C. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis. 1988 Mar;9(3):155–166. doi: 10.1016/0732-8893(88)90025-9. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Vance P., Weissfeld A., Martin R. R. Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia. Antimicrob Agents Chemother. 1978 Nov;14(5):704–709. doi: 10.1128/aac.14.5.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Wiss K., Curvey R., Vance P. H., Steadham J. Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy. Antimicrob Agents Chemother. 1983 Jan;23(1):19–21. doi: 10.1128/aac.23.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]